AI assistant
Sending…
MEDIFAST INC — Director's Dealing 2018
Dec 6, 2018
33899_dirs_2018-12-06_8e4023d9-1c16-4a34-b518-1f2e562ffe5c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2018-12-03
Reporting Person: HALLQUIST CONSTANCE J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-03 | Common Stock | S | 1343 | $153.84 | Disposed | 4687 | Direct |
Footnotes
F1: The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.5529 to $154.2500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
More from MEDIFAST INC
Regulatory Filings
2026
May 26
Annual Report
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 20
Regulatory Filings
2026
Mar 20
Annual Report
2026
Feb 17